SCHEMBL6429130

SCHEMBL6429130

NCC(O)C(Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)NC(=O)c1ccc2ccccc2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 11/20 0.52
CYP3A4 P08684 3/20 0.44
ABCC3 O15438 1/20 0.44
ABCC4 O15439 1/20 0.44
CACNA1F O60840 1/20 0.44
ABCB11 O95342 1/20 0.44
ABCB1 P08183 1/20 0.44
HTR1A P08908 1/20 0.44
DRD2 P14416 1/20 0.44
TACR2 P21452 1/20 0.44
TBXAS1 P24557 1/20 0.44
OPRM1 P35372 1/20 0.44
DRD3 P35462 1/20 0.44
AVPR1A P37288 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
HTR2B P41595 1/20 0.44
CACNA1D Q01668 1/20 0.44
SLC6A3 Q01959 1/20 0.44
KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6444499 0.88 CCR1 (0.48) CCR1CYP3A4ABCC3ABCC4CACNA1F
SCHEMBL6429132 0.82 CYP3A4 (0.58) CCR1CYP3A4ABCC3ABCC4CACNA1F
SCHEMBL5344398 0.82 CYP3A4 (0.58) CCR1CYP3A4ABCC3ABCC4CACNA1F
SCHEMBL7364334 0.82 ALDH1A1 (0.44) CCR1OPRM1OPRK1ALDH1A1GAA
SCHEMBL7294255 0.82 CYP3A4 (0.55) CCR1CYP3A4ABCC3ABCC4CACNA1F
SCHEMBL6444039 0.81 CCR1 (0.44) CCR1CYP3A4ABCC3ABCC4CACNA1F
SCHEMBL7277716 0.80 CYP3A4 (0.45) CCR1CYP3A4ABCC3ABCC4CACNA1F
SCHEMBL6443026 0.79 UGT1A1 (0.47) CCR1CYP3A4ABCC3ABCC4CACNA1F
SCHEMBL7290857 0.78 CTSD (0.48) CCR1CYP3A4ABCC3ABCC4CACNA1F
SCHEMBL8785878 0.78 ALDH1A1 (0.58) ALDH1A1GAAMAPTTP53HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0813868-B1 Retroviral protease inhibitors MONSANTO CO (US) 2005-06-01 EP disclosed
EP-0731088-B1 Retroviral protease inhibitors MONSANTO CO (US) 2000-10-04 EP disclosed
EP-0558603-B1 RETROVIRAL PROTEASE INHIBITORS MONSANTO CO (US) 1998-08-26 EP disclosed
EP-0558630-B1 RETROVIRAL PROTEASE INHIBITORS MONSANTO CO (US) 1998-04-08 EP disclosed
EP-0815856-A2 Retroviral protease inhibitors MONSANTO COMPANY (US) 1998-01-07 EP disclosed
EP-0813868-A2 Retroviral protease inhibitors MONSANTO COMPANY (US) 1997-12-29 EP disclosed
EP-0813867-A2 Retroviral protease inhibitors MONSANTO COMPANY (US) 1997-12-29 EP disclosed
US-5620977-A HUMAN IMMUNODEFICIENCY VIRUS G.D. SEARLE & CO. (US) 1997-04-15 US disclosed
US-5610190-A Retroviral protease inhibitors G. D. SEARLE & CO. (US) 1997-03-11 US disclosed
US-5602175-A HYDROXYETHYLAMINE COMPOUNDS; USEFUL IN TREATMENT OF INFECTIONS CAUSED BY THE HUMAN IMMUNODEFICIENCY VIRUS G.D. SEARLE & CO. (US) 1997-02-11 US disclosed
EP-0731088-A2 Retroviral protease inhibitors MONSANTO COMPANY (US) 1996-09-11 EP disclosed
US-5475027-A Retroviral protease inhibitors G.D. SEARLE & CO. (US) 1995-12-12 US disclosed
EP-0558630-A1 RETROVIRAL PROTEASE INHIBITORS MONSANTO COMPANY (US) 1993-09-08 EP disclosed
EP-0558657-A1 RETROVIRAL PROTEASE INHIBITORS. MONSANTO CO (US) 1993-09-08 EP disclosed
EP-0558673-A1 RETROVIRAL PROTEASE INHIBITORS. MONSANTO CO (US) 1993-09-08 EP disclosed
EP-0554400-A1 RETROVIRAL PROTEASE INHIBITORS. MONSANTO CO (US) 1993-08-11 EP disclosed
WO-1992008701-A1 RETROVIRAL PROTEASE INHIBITORS MONSANTO COMPANY (US) 1992-05-29 WO disclosed
WO-1992008700-A1 RETROVIRAL PROTEASE INHIBITORS MONSANTO COMPANY (US) 1992-05-29 WO disclosed
WO-1992008699-A1 RETROVIRAL PROTEASE INHIBITORS MONSANTO COMPANY (US) 1992-05-29 WO disclosed
WO-1992008698-A1 RETROVIRAL PROTEASE INHIBITORS MONSANTO COMPANY (US) 1992-05-29 WO disclosed